Containers & Packaging company Uflex announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: 66,927 MTPA sales volume during the quarter. Net revenue of Rs 19,689 million. EBITDA of Rs 2,152 million. EBITDA margin at 10.9%. PAT of Rs 377 million. H1FY25 Financial Highlights: 132,577 MTPA sales volume during H1FY25. Net revenue of Rs 38,430 million. EBITDA of Rs 4,384 million. EBITDA margin at 11.4%. PAT of Rs 855 million. Ashok Chaturvedi, Chairman and Managing Director, UFlex Group, said: “We are pleased with the robust growth in sales volume, revenue, and normalized EBITDA for the second consecutive quarter of FY25. The planned commissioning of our aseptic packaging facility in Egypt in FY26 is a key milestone in our global growth strategy, and we are confident of replicating the success of our aseptic packaging business across international markets. With this, we set our sights on a global manufacturing footprint for our aseptic business. We are pleased to announce the successful launch of our 25K aseptic filling and sealing machine. We have delivered the first machine, and it is running successfully in full swing at our customer’s plant. We are extremely confident about the market opportunity and competitive advantage of this machine. At the heart of our business strategy is a steadfast commitment to sustainability, essential for environmental stewardship and long-term value creation. Going ahead, our focus will be on growing our key markets, expanding our footprint, strengthening our global recycling infrastructure, and investing in artificial intelligence and machine learning to reduce our carbon footprint and increase our operational efficiencies. As a company, we take our role in innovation seriously, and we will continue to develop pioneering solutions to deliver on the changing regulatory and consumer landscape”. Rajesh Bhatia, Group president and CFO, UFlex, said: “Our Q2FY25 results reflect our sustained solid YoY growth trajectory, with sales volume up 10.9%, revenue increasing 13.7%, and normalized EBITDA rising 10.7%. In the first half of the current fiscal year, sales volume increased by 10.7%, revenue grew by 13.0%, and normalized EBITDA witnessed an impressive 253.9% increase. This strong first half sets the stage for an even better second half.” "Looking ahead, we are expanding capacity at the Sanand facility, adding 5 billion cartons post-debottlenecking and commissioning 216,000 MTPA virgin PET chips plant at Egypt and 18,000 MTPA CPP line, which will drive the revenue, profitability, growth in FY25 and beyond." “Our Mexico plant showcased outstanding performance in the first half of the fiscal year, achieving 13.3% growth in sales volume and 34.3% increase in revenue.” Result PDF